| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046112735 |
| P356 | DOI | 10.1038/CDDIS.2014.465 |
| P8608 | Fatcat ID | release_otosi6nlmbbvlfldqzm25tvuue |
| P932 | PMC publication ID | 4649538 |
| P698 | PubMed publication ID | 25356874 |
| P5875 | ResearchGate publication ID | 267738358 |
| P50 | author | Carlos F. Menck | Q58336882 |
| Veridiana Munford | Q80192568 | ||
| Annabel Quinet | Q86715015 | ||
| P2093 | author name string | C C M Garcia | |
| C R R Rocha | |||
| D B Vieira | |||
| J E Belizário | |||
| L C de Andrade-Lima | |||
| P2860 | cites work | Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 |
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Malignant gliomas in adults | Q29615708 | ||
| Recent developments in the use of chemotherapy in brain tumours. | Q33232219 | ||
| Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients | Q33359944 | ||
| First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia | Q33360637 | ||
| Repair of O(6)-alkylguanine by alkyltransferases | Q33892810 | ||
| Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production | Q34023873 | ||
| Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer Chemotherapy | Q34159386 | ||
| The resurgence of platinum-based cancer chemotherapy | Q34649255 | ||
| Chemoresistance of glioblastoma cancer stem cells--much more complex than expected | Q35521316 | ||
| Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation | Q35818950 | ||
| Platinum resistance: the role of DNA repair pathways | Q37100598 | ||
| γH2Ax: biomarker of damage or functional participant in DNA repair "all that glitters is not gold!". | Q37924856 | ||
| Molecular mechanisms of cisplatin resistance | Q37926477 | ||
| Molecular mechanisms of temozolomide resistance in glioblastoma multiforme | Q38010801 | ||
| Induction of p53-mediated apoptosis and recovery of chemosensitivity through p53 transduction in human glioblastoma cells by cisplatin | Q38512037 | ||
| Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress. | Q39223156 | ||
| Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma | Q39225065 | ||
| The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma. | Q39602310 | ||
| Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors | Q39628667 | ||
| Kinetics of H2AX phosphorylation after exposure to cisplatin | Q39947163 | ||
| Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks. | Q40033543 | ||
| Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death | Q40086566 | ||
| Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities | Q40433330 | ||
| Sensitizing glioma cells to cisplatin by abrogating the p53 response with antisense oligonucleotides | Q40551019 | ||
| Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines. | Q40662296 | ||
| Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance | Q40675325 | ||
| Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF. | Q40852256 | ||
| Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells. | Q40867830 | ||
| A phase II study of cisplatin and temozolomide in heavily pre-treated patients with temozolomide-refractory high-grade malignant glioma | Q43257160 | ||
| Clinical studies of reversal of drug resistance based on glutathione | Q47785533 | ||
| Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas | Q48350372 | ||
| Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine | Q48479768 | ||
| Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. | Q54154484 | ||
| DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy | Q73645101 | ||
| Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT) | Q82896468 | ||
| Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells | Q83285369 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P921 | main subject | glutathione | Q116907 |
| temozolomide | Q425088 | ||
| P304 | page(s) | e1505 | |
| P577 | publication date | 2014-10-30 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo. | |
| P478 | volume | 5 |
| Q92309382 | 4-Hydroxychalcone Induces Cell Death via Oxidative Stress in MYCN-Amplified Human Neuroblastoma Cells |
| Q35667409 | APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells |
| Q38745839 | Alkylating Agent-Induced NRF2 Blocks Endoplasmic Reticulum Stress-Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis. |
| Q49232671 | Blocking LPA-dependent signaling increases ovarian cancer cell death in response to chemotherapy |
| Q38735518 | DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme. |
| Q58699219 | DNA repair pathways and cisplatin resistance: an intimate relationship |
| Q48089514 | Effect of microRNA-128 on cisplatin resistance of glioma SHG-44 cells by targeting JAG1. |
| Q55107351 | Extremely Low-Frequency Magnetic Fields and Redox-Responsive Pathways Linked to Cancer Drug Resistance: Insights from Co-Exposure-Based In Vitro Studies. |
| Q36622314 | Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines |
| Q46268407 | Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis. |
| Q55001140 | Glutathione: Antioxidant Properties Dedicated to Nanotechnologies. |
| Q37745955 | High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells |
| Q38840489 | Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics |
| Q47125744 | Investigation of platinum nanoparticle properties against U87 glioblastoma multiforme |
| Q58611546 | Mitochondria as a therapeutic target for common pathologies |
| Q30371605 | Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice. |
| Q33905518 | NEK1 kinase domain structure and its dynamic protein interactome after exposure to Cisplatin |
| Q29247923 | NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells |
| Q33867129 | Opportunistic Pathogen Porphyromonas gingivalis Modulates Danger Signal ATP-Mediated Antibacterial NOX2 Pathways in Primary Epithelial Cells |
| Q43709913 | Organotypic brain explant culture as a drug evaluation system for malignant brain tumors. |
| Q28551654 | Phosphatidylinositol 3-Kinase/AKT Pathway Inhibition by Doxazosin Promotes Glioblastoma Cells Death, Upregulation of p53 and Triggers Low Neurotoxicity |
| Q41126084 | Power frequency magnetic field promotes a more malignant phenotype in neuroblastoma cells via redox-related mechanisms |
| Q26744266 | Protein oxidation, UVA and human DNA repair |
| Q50082485 | Redox Paradox: A novel approach to therapeutics-resistant cancer |
| Q53684485 | Survival of rats bearing advanced intracerebral F 98 tumors after glutathione depletion and microbeam radiation therapy: conclusions from a pilot project. |
| Q92701943 | Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy |
| Q91496697 | The balance between NRF2/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells |
| Q38647100 | Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines |
| Q92601852 | xCT (SLC7A11) expression confers intrinsic resistance to physical plasma treatment in tumor cells |
Search more.